Literature DB >> 9719904

Psychiatric disorders and gynecological oncology: a review of the literature.

D S Thompson1, M K Shear.   

Abstract

It is likely that patients with gynecological cancers are at risk for psychiatric disorders such as major depression and anxiety disorders. However, relatively little attention has been focused on studying these women. We review here papers that report rates and treatment of psychiatric illness in women with gynecological cancer. This small literature suggests that depression, anxiety, and adjustment disorders do occur with heightened frequency, and appear to worsen over the course of treatment persisting well after the initial diagnosis and therapy. Antidepressants are reported to be effective but compliance is often a problem. Limitations in this literature include a paucity of research specific to gynecological cancers, small sample sizes in reports that do exist, and minimal differentiation between the specific cancers and their rates of depression and anxiety. There is a clear need for more clinical and research attention to this at-risk population.

Entities:  

Mesh:

Year:  1998        PMID: 9719904     DOI: 10.1016/s0163-8343(98)00030-9

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  9 in total

1.  Randomized controlled trial of collaborative care management of depression among low-income patients with cancer.

Authors:  Kathleen Ell; Bin Xie; Brenda Quon; David I Quinn; Megan Dwight-Johnson; Pey-Jiuan Lee
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

2.  Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer.

Authors:  Kathleen Ell; Kathleen Sanchez; Betsy Vourlekis; Pey-Jiuan Lee; Megan Dwight-Johnson; Isabel Lagomasino; Laila Muderspach; Christy Russell
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

3.  Psychiatric morbidity in outpatients of gynecological oncology clinic in a tertiary care hospital.

Authors:  Rohan Dilip Mendonsa; Prakash Appaya
Journal:  Indian J Psychiatry       Date:  2010-10       Impact factor: 1.759

4.  Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study.

Authors:  Kathleen Ell; Brenda Quon; David I Quinn; Megan Dwight-Johnson; Anjanette Wells; Pey-Jiuan Lee; Bin Xie
Journal:  Gen Hosp Psychiatry       Date:  2007 May-Jun       Impact factor: 3.238

5.  The gynecologic oncology consult: symptom presentation and concurrent symptoms of depression and anxiety.

Authors:  Jeffrey M Fowler; Kristen M Carpenter; Parul Gupta; Deanna M Golden-Kreutz; Barbara L Andersen
Journal:  Obstet Gynecol       Date:  2004-06       Impact factor: 7.661

6.  Sexual self schema as a moderator of sexual and psychological outcomes for gynecologic cancer survivors.

Authors:  Kristen M Carpenter; Barbara L Andersen; Jeffrey M Fowler; G Larry Maxwell
Journal:  Arch Sex Behav       Date:  2008-04-17

7.  A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer.

Authors:  Carlos Blanco; John C Markowitz; David J Hellerstein; Arthur M Nezu; Melanie Wall; Mark Olfson; Ying Chen; Jon Levenson; Maika Onishi; Cindy Varona; Mayumi Okuda; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2018-10-20       Impact factor: 4.872

8.  Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.

Authors:  T M Wagner; R Möslinger; G Langbauer; R Ahner; E Fleischmann; A Auterith; A Friedmann; T Helbich; C Zielinski; E Pittermann; M Seifert; P Oefner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  Prevalence and associated positive psychological variables of depression and anxiety among Chinese cervical cancer patients: a cross-sectional study.

Authors:  Yi-Long Yang; Li Liu; Xiao-Xi Wang; Yang Wang; Lie Wang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.